Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial

Intensive Care Medicine
Philippe MontraversDURAPOP Trial Group

Abstract

Shortening the duration of antibiotic therapy (ABT) is a key measure in antimicrobial stewardship. The optimal duration of ABT for treatment of postoperative intra-abdominal infections (PIAI) in critically ill patients is unknown. A multicentre prospective randomised trial conducted in 21 French intensive care units (ICU) between May 2011 and February 2015 compared the efficacy and safety of 8-day versus 15-day antibiotic therapy in critically ill patients with PIAI. Among 410 eligible patients (adequate source control and ABT on day 0), 249 patients were randomly assigned on day 8 to either stop ABT immediately (n = 126) or to continue ABT until day 15 (n = 123). The primary endpoint was the number of antibiotic-free days between randomisation (day 8) and day 28. Secondary outcomes were death, ICU and hospital length of stay, emergence of multidrug-resistant (MDR) bacteria and reoperation rate, with 45-day follow-up. Patients treated for 8 days had a higher median number of antibiotic-free days than those treated for 15 days (15 [6-20] vs 12 [6-13] days, respectively; P < 0.0001) (Wilcoxon rank difference 4.99 days [95% CI 2.99-6.00; P < 0.0001). Equivalence was established in terms of 45-day mortality (rate difference 0.038, ...Continue Reading

References

Nov 19, 2015·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·C Eckmann

❮ Previous
Next ❯

Citations

Nov 2, 2018·Current Opinion in Infectious Diseases·Jan J De Waele, Ignacio Martin-Loeches
Feb 9, 2019·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·T SchmochM A Weigand
Jan 8, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Noah Wald-Dickler, Brad Spellberg
Oct 18, 2019·Expert Review of Anti-infective Therapy·Philippe MontraversAlexy Tran-Dinh
Nov 23, 2019·Expert Review of Anti-infective Therapy·Filippo AnnoniFabio Silvio Taccone
Feb 20, 2020·European Journal of Anaesthesiology·Michelle S Chew, Bernhard Walder
Oct 1, 2019·Current Opinion in Gastroenterology·Shadia AhmedAndrew Kirby
Apr 3, 2020·Infection & chemotherapy·Hyeri SeokDae Won Park
Jul 8, 2018·Critical Care : the Official Journal of the Critical Care Forum·Adel AlqarniPhilippe Montravers
Jan 20, 2019·Intensive Care Medicine·Jean-François TimsitFrançois Barbier
Sep 29, 2019·Journal of the Anus, Rectum and Colon·Yoshio TakesueKazuhiko Nakajima
Feb 13, 2020·Intensive Care Medicine·Jean-François TimsitMatteo Bassetti
Nov 9, 2019·Intensive Care Medicine·Matteo BassettiPhilippe Montravers
Oct 8, 2020·Current Opinion in Infectious Diseases·Lucie Le Fevre, Jean-François Timsit
Jan 13, 2021·Journal of Pharmacy Practice·Steven M SmokeNicole I Leonida
Aug 6, 2020·Anaesthesia Critical Care & Pain Medicine·Claire RogerMarc Leone
Nov 6, 2020·Current Opinion in Infectious Diseases·Benjamin J SmithKirsty Buising
Dec 29, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xiuwen WuJianan Ren
Jan 5, 2021·Current Opinion in Critical Care·Philippe MontraversAurélie Gouel-Cheron
Dec 17, 2020·The Journal of Surgical Research·Khushboo PatelBethany R Shoulders
Feb 23, 2021·Current Infectious Disease Reports·Aaron J Heffernan, Kerina J Denny
Jul 3, 2021·Life·Sveva Di FrancoMaria Beatrice Passavanti
Jul 25, 2021·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Gary Alan BassLewis J Kaplan
Aug 7, 2021·Surgical Infections·Patrick T DelaplainUNKNOWN Scientific Studies Committee of the Surgical Infection Society
Aug 31, 2021·The Journal of Antimicrobial Chemotherapy·Philippe MontraversUNKNOWN DURAPOP trial group
Sep 21, 2021·Seminars in Respiratory and Critical Care Medicine·Etienne de Montmollin, Jean-François Timsit
Jul 16, 2021·Current Opinion in Infectious Diseases·Sergio ReyesDavid P Nicolau
Sep 26, 2021·Current Opinion in Critical Care·Sharon EinavMarc Leone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.